Unknown

Dataset Information

0

Axon degeneration is key component of neuronal death in amyloid-? toxicity.


ABSTRACT: Depending upon the stimulus, neuronal cell death can either be triggered from the cell body (soma) or the axon. We investigated the origin of the degeneration signal in amyloid ? (A?) induced neuronal cell death in cultured in vitro hippocampal neurons. We discovered that A?1-42 toxicity-induced axon degeneration precedes cell death in hippocampal neurons. Overexpression of Bcl-xl inhibited both axonal and cell body degeneration in the A?-42 treated neurons. Nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1) blocks axon degeneration in a variety of paradigms, but it cannot block neuronal cell body death. Therefore, if the neuronal death signals in A?1-42 toxicity originate from degenerating axons, we should be able to block neuronal death by inhibiting axon degeneration. To explore this possibility we over-expressed Nmnat1 in hippocampal neurons. We found that inhibition of axon degeneration in A?1-42 treated neurons prevented neuronal cell death. Thus, we conclude that axon degeneration is the key component of A?1-42 induced neuronal degeneration, and therapies targeting axonal protection can be important in finding a treatment for Alzheimer's disease.

SUBMITTER: Alobuia WM 

PROVIDER: S-EPMC3918889 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Axon degeneration is key component of neuronal death in amyloid-β toxicity.

Alobuia Wilson M WM   Xia Wei W   Vohra Bhupinder P S BP  

Neurochemistry international 20130929 8


Depending upon the stimulus, neuronal cell death can either be triggered from the cell body (soma) or the axon. We investigated the origin of the degeneration signal in amyloid β (Aβ) induced neuronal cell death in cultured in vitro hippocampal neurons. We discovered that Aβ1-42 toxicity-induced axon degeneration precedes cell death in hippocampal neurons. Overexpression of Bcl-xl inhibited both axonal and cell body degeneration in the Aβ-42 treated neurons. Nicotinamide mononucleotide adenylylt  ...[more]

Similar Datasets

| S-EPMC6665404 | biostudies-literature
| S-EPMC8131740 | biostudies-literature
| S-EPMC8660793 | biostudies-literature
| S-EPMC4046770 | biostudies-literature
| S-EPMC7316712 | biostudies-literature
| S-EPMC6731592 | biostudies-literature
| S-EPMC8709321 | biostudies-literature
| S-EPMC6022692 | biostudies-literature
| S-EPMC6614131 | biostudies-literature
2015-02-12 | E-GEOD-65851 | biostudies-arrayexpress